Advertisement
Canada markets open in 7 hours 15 minutes

  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CAD/USD

    0.7306
    +0.0009 (+0.12%)
     

  • CRUDE OIL

    82.91
    +0.10 (+0.12%)
     

  • Bitcoin CAD

    88,015.23
    -3,215.06 (-3.52%)
     

  • CMC Crypto 200

    1,389.87
    +7.30 (+0.53%)
     

  • GOLD FUTURES

    2,330.50
    -7.90 (-0.34%)
     

  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • NASDAQ futures

    17,424.75
    -239.75 (-1.36%)
     

  • VOLATILITY

    15.97
    +0.28 (+1.78%)
     

  • FTSE

    8,040.38
    -4.43 (-0.06%)
     

  • NIKKEI 225

    37,633.03
    -827.05 (-2.15%)
     

  • CAD/EUR

    0.6816
    -0.0003 (-0.04%)
     

FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?

David Jagielski, The Motley Fool
·3 min read
FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?

The Federal Trade Commission (FTC) has been taking a much more adversarial approach to mergers and acquisitions lately. For instance, it recently said it plans to block the pending deal between pharmaceutical companies Horizon Therapeutics (NASDAQ: HZNP) and Amgen (NASDAQ: AMGN). Does the FTC's recent tough stance on big deals increase the chances that Pfizer's (NYSE: PFE) acquisition of Seagen (NASDAQ: SGEN) will also run into problems?

Continue reading